TickerFactsScreenerDevelopers

Regencell Bioscience Holdings Ltd (RGC) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $153.3K2019: $243.3K2020: $387.0K2021: $59.4K2022: $6.42M$6.42M
2018Cash & Equivalents (USD)2022
Fiscal YearCash & EquivalentsChange YoY
2022$6.42M+10700.7%
2021$59.4K-84.6%
2020$387.0K+59.0%
2019$243.3K+58.7%
2018$153.3K—